P&G Health’s nasal gel tech shows potential against Covid-19

The study assessed the ability of P&G Health’s nasal mucoadhesive gel technology to restrain the SARS-CoV-2 virus from infecting cells it needs for replication. Credit: Felipe Esquivel Reed.



  • P&G Health